CliffBio
small molecule

DOXYCYCLINE HYCLATE

DOXYCYCLINE HYCLATE

Loss of exclusivity—loss of exclusivity
CompanyHIKMA INTERNATIONAL PHARMACEUTICALS LLC

Drug detail

Brand nameDOXYCYCLINE HYCLATE
Active ingredientDOXYCYCLINE HYCLATE
StrengthEQ 50MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 1984
Marketing statusRX

More from HIKMA INTERNATIONAL PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DOXYCYCLINE HYCLATE patent cliff — loss of exclusivity — | CliffBio